P2.11B.03 Circulating Hallmarks of Hyperprogression in NSCLC Upon 1st Line PD-(L)1 Inhibitors Alone or in Combination with Chemotherapy
Journal of Thoracic Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Thoracic Oncology(2024)